Liver transplantation of patients in end-stage cirrhosis

Geoffrey Haydon, James Neuberger

Research output: Contribution to journalReview articlepeer-review

8 Citations (Scopus)


The success of liver transplantation has resulted in its widespread use for end-stage liver disease; 1- and 5-year survival rates of 70-90% and 60-80% respectively have been reported. Indications for assessment for liver transplantation are now evidence-based and early referral is recommended, correlating with improved patient survival. The management of patients on the waiting list for liver transplantation is designed to prevent complications of liver disease and to avoid therapeutic misadventures. Following transplantation, rejection and infection dominate post-operative complications, and improvements in their prevention and treatment have also correlated with improved patient survival. The development and introduction into clinical practice of a variety of immunosuppressive agents has offered a bewildering array of therapeutic options but with a lack of evidence on which to select optimal immunosuppression. Similarly, difficulties remain in the treatment of some of the complications arising from liver transplantation such as recurrence of disease and complications of immunosuppression.
Original languageEnglish
Pages (from-to)1049-1073
Number of pages25
JournalBest Practice & Research: Clinical Gastroenterology
Issue number6
Publication statusPublished - 1 Dec 2000


  • complications
  • liver transplantation
  • indications and timing
  • recurrent disease
  • outcome
  • evaluation


Dive into the research topics of 'Liver transplantation of patients in end-stage cirrhosis'. Together they form a unique fingerprint.

Cite this